2026-05-28T19:40:08Zhttps://keep.lib.asu.edu/oai/request

oai:keep.lib.asu.edu:node-1549882024-12-20T18:25:12Zoai_pmh:alloai_pmh:repo_items

154988 https://hdl.handle.net/2286/R.I.40343 http://rightsstatements.org/vocab/InC/1.0/ All Rights Reserved 2016 2018-08-01T07:38:27 164 pages Doctoral Dissertation Academic theses Text eng Dutta, Dipankar Stabenfeldt, Sarah E Kleim, Jeffrey Nikkhah, Mehdi Sirianni, Rachael Vernon, Brent Arizona State University Partial requirement for: Ph.D., Arizona State University, 2016 Includes bibliographical references (pages Field of study: Bioengineering Stromal cell-derived factor-1α (SDF-1α) and its key receptor, CXCR4 are ubiquitously expressed in systems across the body (e.g. liver, skin, lung, etc.). This signaling axis regulates a myriad of physiological processes that range from maintaining of organ homeostasis in adults to, chemotaxis of stem/progenitor and immune cell types after injury. Given its potential role as a therapeutic target for diverse applications, surprisingly little is known about how SDF-1α mediated signaling propagates through native tissues. This limitation ultimately constrains rational design of interventional biomaterials that aim to target the SDF-1α/CXCR4 signaling axis. One application of particular interest is traumatic brain injury (TBI) for which, there are currently no means of targeting the underlying biochemical pathology to improve prognosis. <br/><br/> Growing evidence suggests a relationship between SDF-1α/CXCR4 signaling and endogenous neural progenitor/stem cells (NPSC)-mediated regeneration after neural injury. Long-term modulation of the SDF-1α/CXCR4 signaling axis is thus hypothesized as a possible avenue for harnessing and amplifying endogenous regenerative mechanisms after TBI. In order to understand how the SDF-1α/CXCR4 signaling can be modulated in vivo, we first developed and characterized a sustained protein delivery platform in vitro. We were the first, to our knowledge, to demonstrate that protein release profiles from poly(D,L,-lactic-co-glycolic) acid (PLGA) particles can be tuned independent of particle fabrication parameters via centrifugal fractioning. This process of physically separating the particles altered the average diameter of a particle population, which is in turn was correlated to critical release characteristics. Secondly, we demonstrated sustained release of SDF-1α from PLGA/fibrin composites (particles embedded in fibrin) with tunable burst release as a function of fibrin concentration. Finally, we contrasted the spatiotemporal localization of endogenous SDF-1α and CXCR4 expression in response to either bolus or sustained release of exogenous SDF-1α. Sustained release of exogenous SDF-1α induced spatially diffuse endogenous SDF-1/CXCR4 expression relative to bolus SDF-1 administration; however, the observed effects were transient in both cases, persisting only to a maximum of 3 days post injection. These studies will inform future systematic evaluations of strategies that exploit SDF-1α/CXCR4 signaling for diverse applications. Biomedical Engineering Cell recruitement Central Nervous System Endogenous stem cells Protein delivery SDF-1/CXCL12 Tissue Engineering Stem Cells Proteins Brain--Wounds and injuries. Novel protein delivery platforms to modulate SDF-1a/CXCR4 signaling in the adult cortex